Macchia, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 7.400
NA - Nord America 6.933
AS - Asia 4.772
SA - Sud America 1.034
AF - Africa 158
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 12
Totale 20.323
Nazione #
US - Stati Uniti d'America 6.731
DE - Germania 2.908
SG - Singapore 2.127
CN - Cina 1.469
SE - Svezia 1.359
BR - Brasile 912
IT - Italia 639
UA - Ucraina 555
FR - Francia 417
GB - Regno Unito 335
IE - Irlanda 319
IN - India 314
FI - Finlandia 233
ID - Indonesia 196
PL - Polonia 184
VN - Vietnam 136
CA - Canada 135
TR - Turchia 124
RU - Federazione Russa 121
HK - Hong Kong 61
JP - Giappone 60
BD - Bangladesh 57
NL - Olanda 55
CI - Costa d'Avorio 54
BE - Belgio 53
CZ - Repubblica Ceca 42
AT - Austria 40
AR - Argentina 39
IQ - Iraq 33
MX - Messico 31
IR - Iran 30
ZA - Sudafrica 29
ES - Italia 27
KR - Corea 27
LT - Lituania 24
SA - Arabia Saudita 20
CO - Colombia 19
EC - Ecuador 19
EG - Egitto 18
MA - Marocco 16
AE - Emirati Arabi Uniti 14
KE - Kenya 14
JM - Giamaica 13
UZ - Uzbekistan 13
EU - Europa 11
PK - Pakistan 11
CH - Svizzera 10
CL - Cile 10
RO - Romania 10
VE - Venezuela 10
IL - Israele 9
PH - Filippine 9
AU - Australia 8
JO - Giordania 8
PY - Paraguay 8
BH - Bahrain 7
GR - Grecia 7
PT - Portogallo 7
RS - Serbia 7
TN - Tunisia 7
UY - Uruguay 7
AL - Albania 6
DZ - Algeria 6
HU - Ungheria 6
AM - Armenia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
BO - Bolivia 5
LK - Sri Lanka 5
LU - Lussemburgo 5
NP - Nepal 5
PE - Perù 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
MT - Malta 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
CR - Costa Rica 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
MY - Malesia 3
NO - Norvegia 3
SN - Senegal 3
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
Totale 20.299
Città #
Chandler 1.363
Singapore 1.055
Ashburn 597
Beijing 344
Jacksonville 321
Dublin 316
San Mateo 260
Nanjing 199
Jakarta 190
Wilmington 181
New York 180
Dearborn 165
Warsaw 163
Munich 158
The Dalles 142
Nürnberg 140
Boston 139
Milan 137
Los Angeles 134
Hefei 132
Bremen 123
Woodbridge 115
Marseille 112
Dallas 110
Ann Arbor 106
Hyderabad 105
Frankfurt am Main 102
Rome 96
São Paulo 93
Izmir 88
Houston 86
Helsinki 85
Lawrence 85
Cattolica 84
Princeton 79
Moscow 77
Fairfield 76
Nanchang 76
Seattle 59
Redwood City 56
Abidjan 54
Brussels 53
Hong Kong 49
Hanoi 45
Toronto 45
Ho Chi Minh City 40
Leawood 40
Santa Clara 38
Zhengzhou 37
Düsseldorf 36
London 36
University Park 36
Turku 35
Chicago 34
Kent 34
Shenyang 34
Hebei 32
Kunming 32
Phoenixville 32
Tokyo 31
Augusta 30
Fremont 29
Lancaster 29
Boardman 28
Stockholm 28
Tianjin 28
Changsha 27
Cambridge 26
Jiaxing 26
Montreal 26
Nuremberg 26
Falls Church 25
Mountain View 25
Seoul 25
Brooklyn 24
Shanghai 24
Norwalk 23
Pune 23
Detroit 22
North York 22
Rio de Janeiro 21
Vienna 21
Amsterdam 20
Auburn Hills 20
San Francisco 20
Brno 19
Guangzhou 19
Hangzhou 19
Johannesburg 19
Atlanta 18
Phoenix 18
Redmond 18
Bexley 17
Lauterbourg 17
Mumbai 16
Wroclaw 16
Belo Horizonte 15
Brasília 15
Denver 15
Lappeenranta 15
Totale 9.776
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 826
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 278
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 200
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 193
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 184
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 180
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 180
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 173
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 171
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 171
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 166
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 163
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 162
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 162
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 162
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 161
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 161
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 159
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 159
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 159
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 158
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 154
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 154
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 154
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 153
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 153
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 152
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 152
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 150
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 149
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 148
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 146
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 145
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 143
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 141
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 140
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 140
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 140
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 140
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 139
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 139
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 139
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 139
In Vivo Portal Dosimetry by an Ionization Chamber 138
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 138
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 137
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 136
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 134
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 134
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 134
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 133
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 132
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 130
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 126
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 126
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 125
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 125
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 125
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 124
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 123
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 122
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 122
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 121
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 121
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 121
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 119
Real time transit dosimetry for the breath-hold radiotherapy technique experience 118
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 117
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 117
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 115
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 114
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 114
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 113
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 113
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 112
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 111
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 109
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 108
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 108
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 107
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 107
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 106
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 106
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 105
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 105
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 105
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 104
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 103
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 103
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 102
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 100
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 99
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 99
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 99
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 99
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 99
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups 99
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 97
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 97
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 96
Totale 14.090
Categoria #
all - tutte 87.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.948


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021849 0 0 0 0 161 48 128 31 129 98 197 57
2021/20221.580 153 107 15 107 111 57 23 216 62 111 308 310
2022/20233.828 521 539 262 610 263 423 223 292 419 79 148 49
2023/20241.701 66 484 75 129 52 215 101 131 20 52 237 139
2024/20253.772 106 84 240 136 419 103 97 175 600 446 729 637
2025/20263.490 1.417 296 552 962 263 0 0 0 0 0 0 0
Totale 20.993